# OnCo record nct06640049 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06640049/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06640049", "NCT06640049" ;
  schema:name "A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China"@en ;
  schema:alternateName "China AZUR-1"@en ;
  schema:description "A phase 2 trial of Dostarlimab in colorectal cancer, run by GlaxoSmithKline, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06640049/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06640049> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2024-10-17" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/msi-high-colorectal/>, <https://onco.cc/cancers/rectal-cancer/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/dostarlimab/> ;
  onco:companies <https://onco.cc/companies/gsk/> .